Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded ― particularly, the risk of infection to ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories (NYSE:ABT) reported first-quarter 2026 results that management said were “aligned with our expectations ...

Shares of Abbott Laboratories (ABT) have seen a small negative price reaction in response to a larger deal for its smaller diagnostic peer Exact Sciences Corporation (EXAS), taking place at a revenue ...

Abbott Diabetes Care said it had received reports of more than 700 injuries that may be associated with malfunctioning sensors. By Amanda Holpuch ByHeart, the maker of the product, has been linked to ...

The S&P 500 has performed well in 2023, but healthcare stocks have lagged behind. Abbott Laboratories continues to lap difficult comparable quarterly earnings reports, but the core business has been ...

Abbott Laboratories cut its full-year earnings outlook to account for a recent acquisition and said a weaker-than-expected ...

Abbott Laboratories (ABT) has reported first-quarter financial results that narrowly beat Wall Street’s forecasts. The pharmaceutical giant announced earnings per share (EPS) of $1.15 U.S., which ...